Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes. [electronic resource]
- Pharmacogenomics Mar 2011
- 327-39 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1744-8042
10.2217/pgs.10.191 doi
Adolescent Antimetabolites, Antineoplastic--pharmacokinetics Child Child, Preschool Cytarabine--pharmacokinetics Drug Resistance, Neoplasm--genetics Female Gene Expression Profiling Humans Leukemia, Myeloid, Acute--blood Male Metabolic Networks and Pathways--genetics Phenotype Prognosis Treatment Outcome Young Adult